HOME >> MEDICINE >> NEWS
ENBREL (Etanercept) Receives FDA Approval For Treatment Of Juvenile Rheumatoid Arthritis

Therapeutic Breakthrough For Rheumatoid Arthritis Becomes First Biologic Response Modifier Approved To Treat Children And Teen-Agers With JRA

SEATTLE - ENBREL® (etanercept) was approved today by the U.S. Food and Drug Administration (FDA) for the treatment of moderately to severely active polyarticular-course juvenile rheumatoid arthritis (JRA) in patients who have had an inadequate response to one or more disease modifying medicines. Today's announcement was made by Immunex Corporation (NASDAQ: IMNX) and Wyeth-Ayerst Pharmaceuticals, a division of American Home Products Corporation (NYSE: AHP), the companies who market ENBREL in North America.

JRA is an autoimmune system disease that strikes children before age sixteen and can cause painful joint swelling, deformity, stunted growth and increased mortality. According to the Arthritis Foundation, JRA affects approximately 50,000 children in the United States. The disease can impair a child's ability to take part in physical activities, make daily activities such as schoolwork more difficult, and affect a child's physical appearance.

"I never thought my daughter would be able to get out of bed in the morning without experiencing extreme pain, much less attend school with her peers on a daily basis," said Erite Freed, the mother of a 15-year-old girl, Lauren Blumenthal, with JRA who participated in the ENBREL JRA clinical trial. "ENBREL has had a dramatic effect on my daughter's life."

"Children with JRA face the possibility of a lifetime of pain and disability," said Daniel J. Lovell, M.D., M.P.H., a pediatric rheumatologist at Children's Hospital Medical Center of Cincinnati and principal investigator of the clinical study on which the JRA indication was based. "Rheumatologists have had limited options to treat children with moderate to severe arthritis. The approval of ENBREL for JRA opens a new era of hope for these children, teen-agers and the
'"/>

Contact: Tim Warner
warnert@immunex.com
206-470-4193
Immunex Corporation
28-May-1999


Page: 1 2 3 4

Related medicine news :

1. ENBREL (etanercept) long-term clinical trial data
2. ENBREL application for early, active rheumatoid arthritis filed with the U.S. Food and Drug Administration
3. Circulation publishes phase I study of ENBREL in patients with chronic heart failure
4. Positive Results Of Pivotal Phase III Trial With ENBREL In Patients With Early, Active Rheumatoid Arthritis
5. ENBREL (Etanercept) Patient And Physician Support Web Site Launched
6. ENBREL Phase III Data Published In Annals Of Internal Medicine
7. Emory Receives $14 Million Federal Grant To Coordinate 50-Site Brain Attack Prevention Trial
8. Cedars-Sinai Medical Center Nursing Administrator Receives Nursing Excellence Award
9. UK Allied Health Professor Receives Patent On Using Lithium With AIDS Drugs
10. UCSF AIDS Research Center Receives Major New Grant From NIH
11. UT Southwestern Receives FDA Grant To Continue Studies Of Cancer-Fighting Drug Not Used For Past 50 Years

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/30/2021)... , ... March 29, 2021 , ... ... the 21st Century , A Virtual Workshop Presented by WCG FDAnews and Cerulean ... 4:30 pm EDT, https://wcg.swoogo.com/modern-sop-and-quality-systems , Are one’s SOPs written for the ...
(Date:3/30/2021)... ... March 29, 2021 , ... According to data released ... reproductive age (13-44) in need of publicly funded contraception live in counties impacted by ... Colorado’s 64 counties have lost some of their Title X resources. , The ...
(Date:3/30/2021)... ... March 29, 2021 , ... Health Literacy Innovations (HLI), a ... confusion due to low health literacy today announces a new partnership with the ... work with ACAP’s member Safety Net Health Plans, those that provide comprehensive health ...
(Date:3/30/2021)... ... ... Dr. Colin Campbell is proud to announce the 1 year anniversary in their new state ... internal medicine and is a primary care specialist who has been practicing for 23 years. ... keep South Jersey healthy one patient at a time. , “Over the past year, Dr. ...
(Date:3/30/2021)... ... March 30, 2021 , ... The COVID-19 ... and survivors; their families; and their caregivers. Crossroads4Hope is addressing the needs of ... emotional support system, MyGo2Support, which meets needs of people impacted by cancer, no ...
Breaking Medicine News(10 mins):
(Date:3/30/2021)... ... March 29, 2021 , ... The University of Texas Health Science Center ... San Antonio Multispecialty and Research Hospital, a destination center for research and treatment of ... In a nod to the COVID-19 pandemic, the ceremony was held virtually. , William ...
(Date:3/30/2021)... ... March 29, 2021 , ... Iora Health ... primary care, has partnered with Devoted Health , one of the fastest-growing ... across Maricopa County and provides seniors with the highest-quality care and experience possible, ...
(Date:3/30/2021)... CITY (PRWEB) , ... March 29, 2021 , ... ... has joined the Vaccine Credential Initiative (VCI), a group bringing together leading health ... record of vaccination status, based on open, interoperable standards. By joining the VCI ...
Breaking Medicine Technology:
Cached News: